Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 1,001–1,033 of 1,033
Nishimoto, A. T., Wiederhold, N. P., Flowers, S. A., Zhang, Q., Kelly, S. L., Morschhäuser, J., Yates, C. M., Hoekstra, W. J., Schotzinger, R. J., Garvey, E. P., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00341-19 · Cited by 52
“collectively are the fourth-leading cause of nosocomial BSI in the United States (6).”
BackgroundInfluentialImpact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection
Levinson, T., Dahan, A., Novikov, A., Paran, Y., Berman, J., & Ben‐Ami, R. (2021) · Mycoses · doi:10.1111/myc.13191 · Cited by 50
Hirakawa, M. P., Chyou, D. E., Huang, D., Slan, A. R., & Bennett, R. J. (2017) · Genetics · doi:10.1534/genetics.117.300295 · Cited by 47
“C. albicans is the fourth most common cause of bloodstream infections in hospitalized patients in the United States, and infections can lead to death in close to 50% of these cases (Gudlaugsson et al. 2003; Wisplinghoff et al. 2004), making an understanding of its biology of pressing importance.”
BackgroundGander-Bui, H. T. T., Schläfli, J., Baumgartner, J., Walthert, S., Genitsch, V., van Geest, G., Galván, J. A., Cardozo, C., Graham Martinez, C., Grans, M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.023 · Cited by 47
Truong, T., Zeng, G., Qingsong, L., Kwang, L. T., Tong, C., Chan, F. Y., Wang, Y., & Seneviratne, C. J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061523 · Cited by 45
Monteiro, P. T., Pais, P., Costa, C., Manna, S., Sá-Correia, I., & Teixeira, M. C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw817 · Cited by 40
“Candida species are recognized as the 4th most common cause of nosocomial infections (1).”
BackgroundSusceptibility patterns of Candida species recovered from Canadian intensive care units
Laverdiere, M., Labbé, A.-C., Restieri, C., Rotstein, C., Heyland, D., Madger, S., & Stewart, T. (2007) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.10.038 · Cited by 42
“In our study, we focused our attention on colonization by Candida species because of the recognized incidence and importance of endogenous Candida bloodstream infections among nonneutropenic ICU patients [7].”
BackgroundYu, Q., Jia, C., Dong, Y., Zhang, B., Xiao, C., Chen, Y., Wang, Y., Li, X., Wang, L., Zhang, B., et al. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.02.008 · Cited by 42
“Nowadays, the frequency of opportunistic fungal infections is on the rise, due to the growing population of immunocompromised patients and those individuals suffered from organ transplantation, chemotherapy or antibiotic abuse (LaFayette et al., 2010; Gudlaugsson et al., 2003; Wisplinghoff et al., 2004).”
BackgroundBairwa, G., Rasheed, M., Taigwal, R., Sahoo, R., & Kaur, R. (2014) · Biochemical Journal · doi:10.1042/bj20130757 · Cited by 36
Wiederhold, N. P., Najvar, L. K., Fothergill, A. W., Bocanegra, R., Olivo, M., McCarthy, D. I., Kirkpatrick, W. R., Fukuda, Y., Mitsuyama, J., & Patterson, T. F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04228-14 · Cited by 36
Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital
Luzzati, R., Allegranzi, B., Antozzi, L., Masala, L., Pegoraro, E., Azzini, A., & Concia, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01268.x · Cited by 33
“were reported to cause 9% of BSIs detected in 49 USA hospitals [12].”
BackgroundFungal Infection in the Brain: What We Learned from Intravital Imaging
Shi, M., & Mody, C. H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00292 · Cited by 33
Alp, S., Arikan‐Akdagli, S., Gulmez, D., Ascioglu, S., Uzun, O., & Akova, M. (2015) · Mycoses · doi:10.1111/myc.12349 · Cited by 32
Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation
Caldara, M., & Marmiroli, N. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.06.023 · Cited by 31
Baker, K. M., Hoda, S., Saha, D., Gregor, J. B., Georgescu, L., Serratore, N. D., Zhang, Y., Cheng, L., Lanman, N. A., & Briggs, S. D. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02250-21 · Cited by 30
“C andida infections are a major health concern due to the increased frequency of infections and the development of drug resistance (1, 2).”
BackgroundFerreira-Gomes, M., Wich, M., Böde, S., Hube, B., Jacobsen, I. D., & Jungnickel, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.698849 · Cited by 29
“However, this benign commensal can also cause severe infections in immunocompromised hosts, being a common cause of nosocomial infections (1, 2).”
BackgroundNaglik, J. R. (2014) · New Journal of Science · doi:10.1155/2014/390241 · Cited by 29
Mohammad, H., Elghazawy, N. H., Eldesouky, H. E., Hegazy, Y. A., Younis, W., Avrimova, L., Hazbun, T., Arafa, R. K., & Seleem, M. N. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00215 · Cited by 29
Antifungal resistance does not necessarily affect Candida glabrata fitness
Borghi, E., Andreoni, S., Cirasola, D., Ricucci, V., Sciota, R., & Morace, G. (2014) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000100 · Cited by 25
Yeoh, S. F., Lee, T. J., Chew, K. L., Lin, S., Yeo, D., & Setia, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165676 · Cited by 20
“didemia is the fourth most common blood infection in nosocomial settings, especially in ICU settings.(17) It is important”
BackgroundOrasch, C., Mertz, D., Garbino, J., van Delden, C., Emonet, S., Schrenzel, J., Zimmerli, S., Damonti, L., Mühlethaler, K., Imhof, A., et al. (2018) · Journal of Infection · doi:10.1016/j.jinf.2017.12.018 · Cited by 19
Suzuki, H., Perencevich, E. N., Diekema, D. J., Livorsi, D. J., Nair, R., Kralovic, S. M., Roselle, G. A., & Goto, M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab105 · Cited by 20
Lee, Y., Liston, S. D., Lee, D., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.104432 · Cited by 18
Bacterial Nitric Oxide Synthase Is Required for the Staphylococcus aureus Response to Heme Stress
Surdel, M. C., Dutter, B. F., Sulikowski, G. A., & Skaar, E. P. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00081 · Cited by 18
Synergistic Antifungal Activity of Berberine Derivative B-7b and Fluconazole
Li, L. P., Liu, W., Liu, H., Zhu, F., Zhang, D. Z., Shen, H., Xu, Z., Qi, Y. P., Zhang, S. Q., Chen, S. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126393 · Cited by 17
Udawatte, N. S., Kang, S. W., Wang, Y., Arumugam, T. V., & Seneviratne, C. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00511 · Cited by 17
Use of Haploid Model of Candida albicans to Uncover Mechanism of Action of a Novel Antifungal Agent
Truong, T., Suriyanarayanan, T., Zeng, G., Le, T. D., Liu, L., Li, J., Tong, C., Wang, Y., & Seneviratne, C. J. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00164 · Cited by 16
“Systemic candidiasis is reported to have a mortality rate as high as 40% (Wisplinghoff et al., 2004).”
BackgroundRashid, S., Correia-Mesquita, T. O., Godoy, P., Omran, R. P., & Whiteway, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.764711 · Cited by 15
“albicans a significant medical issue (Wisplinghoff et al., 2004; Tournu and Van Dijck, 2012; Mathé and Van Dijck, 2013).”
BackgroundAdaptation of Candida albicans to Reactive Sulfur Species
Chebaro, Y., Lorenz, M., Fa, A., Zheng, R., & Gustin, M. (2017) · Genetics · doi:10.1534/genetics.116.199679 · Cited by 11
Zhang, X., Bai, J., Wu, C.-L., Wu, Y., Zhao, Y., Song, W.-M., & Luo, X.-P. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.10.009 · Cited by 11
Norimatsu, Y., Morii, D., Kogure, A., Hamanaka, T., Kuwano, Y., Yokozawa, T., & Oda, T. (2017) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2017.03.002 · Cited by 8
Post-transcriptional control of antifungal resistance in human fungal pathogens
Sharma, C., & Kadosh, D. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2080527 · Cited by 6
“…spp. is the most common cause of healthcare-associated bloodstream infections (BSIs) and the fourth leading cause of hospital-acquired BSIs in the United States with about a 50% attributable mortality rate (Edmond et al. 1999; Wisplinghoff et al. 2004; Denning and Bromley 2015; Toda et al. 2019).”
BackgroundDe Oliveira, M. É., De Lima, W. G., Alves, C. F. B., Herrera, K. M. S., Santos, P. C., De Souza, D. D. G., Dos Santos, M. E. S. M., Ribeiro, R. I. D. M. D. A., Thomé, R. G., Dos Santos, H. B., et al. (2022) · Brazilian Journal of Development · doi:10.34117/bjdv8n5-543 · Cited by 3
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.